The Impact of Direct-to-Consumer Sales on Pharma and Drug Costs
TL;DR Summary
Selling drugs directly to consumers by pharmaceutical companies is unlikely to significantly lower drug costs for patients, as cash prices are higher than insurance prices and direct purchases do not contribute to insurance deductibles or out-of-pocket limits.
- Why direct-to-consumer sales are unlikely to significantly lower drug costs statnews.com
- Weight-Loss Drugs Are Now Selling Direct to Consumer. What It Means for Big Pharma. Barron's
- DTC Prescription Care Expands with Increased Focus on GLP-1 Medications for Weight Management and Diabetes geneonline.com
- Indegene Exec On DTP Distribution As A ‘Tactical Solution’, Feasibility Of MFN Model insights.citeline.com
- Trade-offs abound as big pharma makes direct-to-consumer transition Yahoo Finance
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
1 min
vs 2 min read
Condensed
87%
291 → 37 words
Want the full story? Read the original article
Read on statnews.com